Grow your wealth. Expand your knowledge. Leverage strategic insight.

The Investor Standard delivers world-class market analysis, stock recommendations, and exclusive insights to help you make smarter investment decisions and stay ahead of the market.

The new wave of ex dividend stocks in April, where income still matters in a volatile market

A fresh wave of income April 2026 is shaping up as one of the busier ex dividend periods of the…

Dividend Portfolio Series: 5 Growth Dividend Stocks You Should Own in 2026

1. Apple Inc.: NASDAQ Apple Inc. is viewed as a strong dividend stock because it pairs dependable income with steady…

SpaceX, OpenAI and Anthropic Could Define the Next IPO Cycle, and Test the Limits of the AI Boom

The next great IPO wave The next IPO cycle is shaping as something bigger than a typical listing window, with…

Highlighted Insights

Stay ahead with our top market stories, stock recommendations, and exclusive research.

An Outlook on ASX: Ramsay Health Care (RHC)

Business Summary & Overview Ramsay Health Care is a prominent international hospital operator offering acute care, surgical services, mental health support, and specialised medical treatments.…

Ankit Tadanki
5 Min Read

Value’s revenge, why boring, cash rich businesses may be the surprise winners of 2026

The shift back toward value is getting harder to ignore For years, owning “boring” businesses felt like sitting on the…

ASX Weekly Market Wrap

A Bounce, But Not a Clean Recovery Australian equities finally broke their losing streak, with the ASX 200 finishing the…

What Caused the Meta Layoffs?

Meta’s layoffs in recent years have not only reshaped its internal organisation but also influenced wider expectations around job stability…

Featured Investments (Stock Picks)

ASX Weekly Market Wrap

Markets Are Rolling Over, But the Rotation Matters More Australian equities have now extended their…

NEXTDC (ASX: NXT) Investment Analysis

Wiring Australia for the AI Supercycle NEXTDC sits at the centre of one of the…

Unlock Smarter Investing

Gain access to independent ASX insights, exclusive stock picks, and in-depth research trusted by founders, boards, and investors.

ASX Weekly Market Wrap

RBA Rate Hike Triggers Tech Selloff Market overview The ASX weekly market wrap for the…

Investor Insights, Delivered

Unlock expert insights, stock recommendations, and market analysis – all in one place. Get the latest market news and stock picks instantly.

Explore More Insights

IperionX Short Seller Allegations: Why Investors See Opportunity in the Fallout

A Critical Minerals Darling Under Fire The short-seller spotlight has swung into IperionX, the U.S. based, ASX-listed titanium producer championed…

How ESG Investing is Driving Venture Capital Decisions Down Under

In recent years, Environmental, Social, and Governance (ESG) considerations have become pivotal in shaping venture capital (VC) investment strategies in…

ASX Diverges on Shocks: Banks Prop, Health & Tech Slide as Domino’s Pops, CSL Sinks

ASX Diverges on Shocks ASX diverges on shocks as headline-driven moves overwhelm the Wall Street lead. By late morning. the…

ETF Investing in Australia: A Practical Guide for Busy Investors

Exchange traded funds have become the default building blocks for Australian portfolios because they provide broad diversification, transparent rules, and…

GlenTinto and the Copper Crunch: BHP Feels the Pressure

The mining sector has been rocked by the news that Rio Tinto and Glencore have revived talks on a $300…

Investment Analysis: Mesoblast Ltd (ASX: MSB)

Business Summary Mesoblast Limited specializes in developing allogeneic, “off‑the‑shelf” cellular medicines designed to treat severe inflammatory conditions. The company’s late‑stage…

Socials

Follow US